Synthesis and Biological Evaluation of Novel 4-indolyl-5-phenyl(indolyl)- 1,2-dihydropyrazol-3-ones as Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors

Author(s): Hong Yin, Fengying Sui, Xinji Yang, Yingying Shangguan, Guojie Song.

Journal Name: Letters in Drug Design & Discovery

Volume 9 , Issue 8 , 2012

Become EABM
Become Reviewer


Nineteen novel 4-indolyl-5-phenyl(indolyl)-1,2-dihydropyrazol-3-ones were synthesized and evaluated for their GSK-3β inhibitory activity. Half of the tested compounds showed moderate GSK-3β inhibitory activity. Preliminary structure-activity relationships were discussed, which showed that the presence of 3,4,5-trimethoxy group on the benezene ring enhanced potency while the existence of an electron-withdrawing group at the 4-position of the benezene ring deceased activity. Compounds 11c and 14, the most potent compounds with IC50 values of 9.28 and 8.98 μM, respectively, would be promising candidates for further development of novel GSK-3β inhibitors.

Keywords: 4-Indolyl-5-phenyl(indolyl)-1, 2-dihydropyrazol-3-ones, Synthesis, GSK-3β inhibitors, metabolism, Staurosporine, biochemical properties, Mammalian GSK-3, pyrazolone ring, Val135

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [780 - 788]
Pages: 9
DOI: 10.2174/157018012802652912
Price: $58

Article Metrics

PDF: 9